Fig. 3. PPAR
activation increases p16 protein levels in 2BS and WI-38 cells. 2BS and WI-38 cells were transfected with the expression plasmids pcDNA3.1 (vector), pcDNA3.1-PPAR
(PPAR
), pSilencer 2.1-U6 neo (RNAi vector) or pSilencer-PPAR
(siPPAR
) and treated, as indicated, with 20 µM troglitazone or DMSO (vehicle) for 72 hours. (A) Western blot analysis of PPAR
and p16INK4
expression in vector-transfected or PPAR
-transfected cells. (B) Western blot analysis of PPAR
and p16INK4
expression in RNAi-vector-transfected or siPPAR
-transfected cells. Western blotting was performed using specific antibodies against PPAR
and p16INK4
as indicated. The β-actin lane served as a loading control.